MarginsXMarginsX
Home › Markets › Health Care › CERS

Cerus Corporation (CERS)

CERS trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$1.86
-6.30% on the day
Market cap
$375.6M
Small cap
Revenue · 2025
$233.8M
+16.1% on 2024
Net income · 2025
-$15.6M
-6.7% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1020214/000119312526085678/0001193125-26-085678-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerCERS on Nasdaq
SectorHealth Care
IndustryMedical/Dental Instruments
CountryUnited States
IPO year1997
SEC CIK0001020214
SEC industry codeSurgical & Medical Instruments & Apparatus
Incorporated inDE

Financials · 2025

LineValue
Revenue$233.8M
Net income-$15.6M
Operating income-$8.7M
Net margin-6.7%
Operating margin-3.7%
Revenue growth+16.1%
Cash$20.0M
Total assets$221.9M
P/E (computed)Net income was not positive
P/S (computed)1.6×

Warning signs

Cash runway
Cash-flow positive
$16.4M cash at September 30, 2026
Share count, 1 year
+5.1%
2025-10-17 to 2026-10-16 · +11.5% over 3 years
Going-concern doubt
No
10-Q filed November 2, 2026
Insider net buying, 12 months
-$3.1M
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-02
Cash and burn$16.4M cash; operating cash flow $874K a quarter.Report 2026-09-30
Shares outstanding201,954,184 (2026-10-16); 192,087,501 a year earlier; 181,197,000 three years earlier.Cover page 2026-10-16
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months1 S-3/F-3 shelf filings; 0 424B5 takedownsLatest 2026-11-02
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorErnst & Young LLP, San Francisco, California, United StatesPCAOB Form AP 2026-03-16
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $3.1M on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$57.7M-$550K$3.0M$16.4MNo debt tags$254.2M10-Q 2026-11-02
Q2 2026
2026-06-30
$57.4M-$2.9M-$2.7M$18.0MNo debt tags$249.2M10-Q 2026-07-30
Q1 2026
2026-03-31
$53.7M-$1.6M-$3.0M$27.9MNo debt tags$244.2M10-Q 2026-04-30
Q4 2025
2025-12-31
$85.4M-$2.2M$6.2M$20.0MNo debt tags$233.8M10-K 2026-03-02
Q3 2025
2025-09-30
$52.7M-$19K$1.9M$15.7MNo debt tagsNeeds four quarters10-Q 2026-11-02
Q2 2025
2025-06-30
$52.4M-$5.7M-$2.4M$16.0MNo debt tagsNeeds four quarters10-Q 2026-07-30
Q1 2025
2025-03-31
$43.2M-$7.7M-$844K$19.5MNo debt tagsNeeds four quarters10-Q 2026-04-30
Q4 2024
2024-12-31
Not filed-$2.5M$4.9M$20.3MNo debt tags$201.3M10-K 2026-03-02

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering documentS-32026-11-02
Latest annual report10-K2026-03-02
Latest quarterly / interim10-Q2026-11-02
Latest current report8-K2026-11-02
Latest proxyDEFA14A2026-04-22

Source: SEC EDGAR submissions feed, 1,001 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-1.5%
1 month-11.9%
3 months-29.9%
Year to date-3.4%
1 year+24.4%
From 52-week high-39.3%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medical/Dental Instruments

TickerCompanyPriceDayMarket cap
BWAYBrainsWay Ltd.$9.39-7.12%$376.8M
EMBCEmbecta Corp.$6.25-3.25%$354.1M
SIShoulder Innovations Inc.$20.45-1.16%$427.9M
MOBIMobia Medical Inc.$13.15-0.15%$438.3M
MDXGMiMedx Group Inc$3.18-0.93%$464.0M
CARLCarlsmed Inc.$17.35+1.34%$475.5M
INFUInfuSystems Holdings Inc.$14.79+0.48%$296.3M
RCELAvita Medical Inc.$15.22-2.62%$478.2M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier